東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Innovative Approaches to Combat Trip...

Akingbesote, Ngozi Damilola Chidumebi,

FindBook

Google Book

Amazon

博客來

Innovative Approaches to Combat Triple-Negative Breast Cancer: Integrating Metabolic Modulation, Advanced Therapies, and Lifestyle Interventions /

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Innovative Approaches to Combat Triple-Negative Breast Cancer: Integrating Metabolic Modulation, Advanced Therapies, and Lifestyle Interventions // Ngozi Damilola Chidumebi Akingbesote.
作者:	Akingbesote, Ngozi Damilola Chidumebi,
面頁冊數:	1 electronic resource (235 pages)
附註:	Source: Dissertations Abstracts International, Volume: 86-12, Section: B.
Contained By:	Dissertations Abstracts International86-12B.
標題:	Oncology. -
電子資源:	https://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=31842527
ISBN:	9798286426232

Innovative Approaches to Combat Triple-Negative Breast Cancer: Integrating Metabolic Modulation, Advanced Therapies, and Lifestyle Interventions /
Akingbesote, Ngozi Damilola Chidumebi,

Innovative Approaches to Combat Triple-Negative Breast Cancer: Integrating Metabolic Modulation, Advanced Therapies, and Lifestyle Interventions /Ngozi Damilola Chidumebi Akingbesote. - 1 electronic resource (235 pages)

Source: Dissertations Abstracts International, Volume: 86-12, Section: B.

Triple-negative breast cancer (TNBC), an aggressive and often lethal subtype of breast cancer, continues to challenge researchers and clinicians due to its poor prognosis and limited therapeutic options. This thesis explores novel therapeutic strategies that integrate metabolic modulation, advanced radionuclide therapies, and lifestyle interventions to combat TNBC effectively.The first component investigates metabolic scaling and its implications for cancer metabolism. Gene and protein expression analyses across species reveal that metabolic processes, including oxidative metabolism and detoxification, scale inversely with body mass. This foundational insight underscores the importance of systemic metabolic regulation in understanding cancer progression.In the realm of cancer therapy, sodium-glucose cotransporter 2 (SGLT2) inhibitors, such as dapagliflozin, demonstrate potential as metabolic modulators. By reducing glucose uptake and insulin levels, these inhibitors enhance chemotherapy's efficacy, particularly in TNBC with specific genetic profiles. This research - to our knowledge, the first to apply precision medicine approaches to the use of metabolic therapy for breast cancer - highlights the promise of metabolism-targeting therapies tailored to individual tumor characteristics.Advances in targeted alpha therapy (TAT) are exemplified by the development of 225Ac-doped poly(lactic-co-glycolic acid) nanoparticles. These nanoparticles improve radionuclide retention and selectively deliver therapeutic doses to cancer cells, minimizing systemic toxicity. This innovation offers a new avenue for precise and effective radiotherapy in TNBC.Lifestyle interventions, particularly aerobic exercise, emerge as critical adjuncts in TNBC treatment. Exercise enhances systemic metabolism, reduces inflammation, and modulates the tumor microenvironment, improving immune infiltration and the efficacy of checkpoint inhibitors such as pembrolizumab. Exercise-induced metabolites, including beta-alanine and fish oil components, show potential as therapeutic adjuvants, further expanding the scope of non-pharmacological cancer therapies.Finally, this work emphasizes the impact of energy balance, exploring how obesity and related metabolic dysregulation influence TNBC progression and therapeutic responses. By addressing energy imbalance through caloric restriction and exercise, significant improvements in treatment outcomes and patient quality of life are achievable.This thesis integrates these interdisciplinary approaches, offering a comprehensive framework for advancing TNBC treatment. By uniting precision medicine, innovative therapies, and lifestyle modifications, it lays the groundwork for personalized and effective strategies against the most lethal form of breast cancer.

English

ISBN: 9798286426232Subjects--Topical Terms:

751006
Oncology.
Subjects--Index Terms:

Immuno-metabolism

Innovative Approaches to Combat Triple-Negative Breast Cancer: Integrating Metabolic Modulation, Advanced Therapies, and Lifestyle Interventions /
LDR:04420nmm a22004573i 4500 001 2433786
005 20250905091013.5
006 m o d
007 cr|nu||||||||
008 261011s2025 miu||||||m |||||||eng d
020 $a 9798286426232
035 $a (MiAaPQD)AAI31842527
035 $a AAI31842527
040 $a MiAaPQD $b eng $c MiAaPQD $e rda
100 1 $a Akingbesote, Ngozi Damilola Chidumebi, $e author. $3 3823536
245 1 0 $a Innovative Approaches to Combat Triple-Negative Breast Cancer: Integrating Metabolic Modulation, Advanced Therapies, and Lifestyle Interventions / $c Ngozi Damilola Chidumebi Akingbesote.
264 1 $a Ann Arbor : $b ProQuest Dissertations & Theses, $c 2025
300 $a 1 electronic resource (235 pages)
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
500 $a Source: Dissertations Abstracts International, Volume: 86-12, Section: B.
500 $a Advisors: Perry, Rachel J. Committee members: Schalper, Kurt; Chung, Jean-Ju; Lustberg, Maryam; Fan, Daping; Zenisek, David.
502 $b Ph.D. $c Yale University $d 2025.
520 $a Triple-negative breast cancer (TNBC), an aggressive and often lethal subtype of breast cancer, continues to challenge researchers and clinicians due to its poor prognosis and limited therapeutic options. This thesis explores novel therapeutic strategies that integrate metabolic modulation, advanced radionuclide therapies, and lifestyle interventions to combat TNBC effectively.The first component investigates metabolic scaling and its implications for cancer metabolism. Gene and protein expression analyses across species reveal that metabolic processes, including oxidative metabolism and detoxification, scale inversely with body mass. This foundational insight underscores the importance of systemic metabolic regulation in understanding cancer progression.In the realm of cancer therapy, sodium-glucose cotransporter 2 (SGLT2) inhibitors, such as dapagliflozin, demonstrate potential as metabolic modulators. By reducing glucose uptake and insulin levels, these inhibitors enhance chemotherapy's efficacy, particularly in TNBC with specific genetic profiles. This research - to our knowledge, the first to apply precision medicine approaches to the use of metabolic therapy for breast cancer - highlights the promise of metabolism-targeting therapies tailored to individual tumor characteristics.Advances in targeted alpha therapy (TAT) are exemplified by the development of 225Ac-doped poly(lactic-co-glycolic acid) nanoparticles. These nanoparticles improve radionuclide retention and selectively deliver therapeutic doses to cancer cells, minimizing systemic toxicity. This innovation offers a new avenue for precise and effective radiotherapy in TNBC.Lifestyle interventions, particularly aerobic exercise, emerge as critical adjuncts in TNBC treatment. Exercise enhances systemic metabolism, reduces inflammation, and modulates the tumor microenvironment, improving immune infiltration and the efficacy of checkpoint inhibitors such as pembrolizumab. Exercise-induced metabolites, including beta-alanine and fish oil components, show potential as therapeutic adjuvants, further expanding the scope of non-pharmacological cancer therapies.Finally, this work emphasizes the impact of energy balance, exploring how obesity and related metabolic dysregulation influence TNBC progression and therapeutic responses. By addressing energy imbalance through caloric restriction and exercise, significant improvements in treatment outcomes and patient quality of life are achievable.This thesis integrates these interdisciplinary approaches, offering a comprehensive framework for advancing TNBC treatment. By uniting precision medicine, innovative therapies, and lifestyle modifications, it lays the groundwork for personalized and effective strategies against the most lethal form of breast cancer.
546 $a English
590 $a School code: 0265
650 4 $a Oncology. $3 751006
650 4 $a Endocrinology. $3 610914
650 4 $a Immunology. $3 611031
650 4 $a Nanotechnology. $3 526235
653 $a Immuno-metabolism
653 $a Immunotherapy
653 $a Metabolic scaling
653 $a Obesity
653 $a PLGA nanoparticle
653 $a Triple negative breast cancer
690 $a 0992
690 $a 0409
690 $a 0982
690 $a 0652
710 2 $a Yale University. $b Cellular and Molecular Physiology. $e degree granting institution. $3 3823537
720 1 $a Perry, Rachel J. $e degree supervisor.
773 0 $t Dissertations Abstracts International $g 86-12B.
790 $a 0265
791 $a Ph.D.
792 $a 2025
856 4 0 $u https://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=31842527